INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• EDC Powers End-To-End Data Management In Pharma-Sponsored Trials

  As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.

• Vaccine Trial Sees >90% eCOA Adherence

  Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.

• Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders

  Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.

• Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM

  Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early. 

• Clinical Trial Technology Built For Confidence And Clarity

  10/6/2025

  Seamlessly integrate IRT, eCOA, patient and site payments, and travel management, with this patented technology that connects all the moving parts of a trial into one intelligent system.

• Driving Diversification And Reach With Tech In Community DCTs

  3/20/2025

  Learn how technology, when used correctly, can accelerate trial timelines and drive patient diversification in community-based decentralized clinical trials (DCTs).

• Looking Beyond Weight Loss In The Obesity Pandemic: What's Next?

  7/12/2024

  Here, we analyze the current landscape of obesity management, underscoring the critical need for comprehensive approaches that prioritize overall well-being beyond simple weight reduction.

• Oncology: The eCOA For Restored Control And Quality Science

  3/25/2026

  This live demonstration showcases an end-to-end eCOA workflow from both the patient and site perspectives, highlighting how symptom reporting and episodic events are captured and managed.

• Wearables 101: Foundations, Regulations, And Real-World Applications

  7/16/2024

  Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.